Kitasamycin Premix Market

Kitasamycin is an antibiotic medicine. Mainly applied in pigs feed, chickens feed and cows feed. It can elevate feed conversion rate, stimulate growth of young animals and increase culture benefits.Prevention of infectious respiratory diseases of livestock and poultry caused by G+ bacteria, cure necrotic enteritis and decrease occurrence rate of intestinal diseases.
Kitasamycin Premix Market contains market size and forecasts of Kitasamycin Premix in global, including the following market information:
Global Kitasamycin Premix Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Kitasamycin Premix Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Kitasamycin Premix companies in 2021 (%)
The global Kitasamycin Premix market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Kitasamycin Premix include Zhejiang Esigma Animal Health, Chongqing Saipunasi Technology, Hangzhou Ailimai Animal Pharmaceutical, Guangdong Cocan Bio-Pharmaceutical, Vega Pharma Limited, Shijiazhuang ZDHF Stock-Raising and Xi'an Harmonious Natural Bio-Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Kitasamycin Premix manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• 0.1
• 0.5
• Other

• Livestock
• Poultry

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Kitasamycin Premix revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Kitasamycin Premix revenues share in global market, 2021 (%)
• Key companies Kitasamycin Premix sales in global market, 2017-2022 (Estimated), (Kiloton)
• Key companies Kitasamycin Premix sales share in global market, 2021 (%)

• Zhejiang Esigma Animal Health
• Chongqing Saipunasi Technology
• Hangzhou Ailimai Animal Pharmaceutical
• Guangdong Cocan Bio-Pharmaceutical
• Vega Pharma Limited
• Shijiazhuang ZDHF Stock-Raising
• Xi'an Harmonious Natural Bio-Technology